Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AgAuUSA who wrote (120)	11/15/1996 2:32:00 PM
From: scaram(o)uche	of 2742

Message from greg pfau on Nov 15 1996 6:57AM EST This may become a long hold. Cistron needs a partner to commercialize this molecule. Clinical trials will be long and expensive. ////////////////////////////////////// Dr. Pfau....... CIST is a reagents company. Repeat that 10 times and see if you can analyze your investment on that basis. Regarding your statement that Cistron has published a single manuscript......... Cistron is a small reagents company that had the smarts to get exclusive license to a big-time reagent. If you want references, try a medline for the individuals who led the research that was licensed by CIST, Philip Auron and "Mr. IL-1", Charles Dinarello. You started early in this thread saying that there was no way that CIST would win an award from IMNX. You were wrong. When the award did come through, you jumped on board, and now you're complaining that a reagents company will need a partner to run clinical trials with IL-1, when (1) they have already licensed the molecule to two companies for pharma research programs, and (2) they have expressed no interest in the independent development of therapeutics.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next